Inspira Technologies Oxy BHN (Inspira Technologies Oxy BHN) EBIT : $-17.01 Mil (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Inspira Technologies Oxy BHN EBIT?

Inspira Technologies Oxy BHN's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2023 was $-2.76 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2023 was $-17.01 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Inspira Technologies Oxy BHN's annualized ROC % for the quarter that ended in Jun. 2023 was -294.78%. Inspira Technologies Oxy BHN's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -311.61%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

Inspira Technologies Oxy BHN EBIT Historical Data

The historical data trend for Inspira Technologies Oxy BHN's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inspira Technologies Oxy BHN EBIT Chart

Inspira Technologies Oxy BHN Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

-4.57

-7.22

-17.13

-14.89

-11.29

Inspira Technologies Oxy BHN Quarterly Data
	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23
EBIT	Get a 7-Day Free Trial											-3.54	-7.79	-2.92	-2.76	-

Competitive Comparison of Inspira Technologies Oxy BHN's EBIT

For the Medical Devices subindustry, Inspira Technologies Oxy BHN's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inspira Technologies Oxy BHN's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inspira Technologies Oxy BHN's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Inspira Technologies Oxy BHN's EV-to-EBIT falls into.

Inspira Technologies Oxy BHN EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-17.01 Mil.

Inspira Technologies Oxy BHN (NAS:IINNW) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Inspira Technologies Oxy BHN's annualized ROC % for the quarter that ended in Jun. 2023 is calculated as:

	ROC % (Q: Jun. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Mar. 2023 )	+	Invested Capital (Q: Jun. 2023 ))	/ count )
=	-12.192 * ( 1 - 0% )	/	( (2.277	+	5.995)	/ 2 )
=	-12.192	/	4.136
=	-294.78 %

where

	Invested Capital		(Q: Mar. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	13.408	-	1.541	-	( 11.498	-	max(0, 2.279	-	11.869	+	11.498	))
=	2.277

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	10.84	-	1.521	-	( 3.324	-	max(0, 2.268	-	9.323	+	3.324	))
=	5.995

Note: The Operating Income data used here is four times the quarterly (Jun. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Inspira Technologies Oxy BHN's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Mar. 2023		Q: Jun. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-11.056	/	( ( (1.539 + max(-1.972, 0))	+	(1.517 + max(4.04, 0)) )	/	2 )
=	-11.056	/	( ( 1.539	+	5.557 )	/	2 )
=	-11.056	/	3.548
=	-311.61 %

where Working Capital is:

	Working Capital		(Q: Mar. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0)	-	(1.541	+	0	+	0.431)
=	-1.972

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	5.999)	-	(1.521	+	0	+	0.438)
=	4.04

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Inspira Technologies Oxy BHN's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2023 )
	=	-17.008	/	0.000
	=	%

Inspira Technologies Oxy BHN EBIT Related Terms

Thank you for viewing the detailed overview of Inspira Technologies Oxy BHN's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Inspira Technologies Oxy BHN (Inspira Technologies Oxy BHN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inspira Technologies Oxy BHN Ltd (NAS:IINNW) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

IINN:USA

Address

2 Ha-Tidhar Street, Ra'anana, ISR, 4366504

Website

http://www.inspira-technologies.com

Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.